Literature DB >> 12752354

Diagnostic investigation rates and use of prescription and non-prescription medications amongst dyspeptics: a population-based study of 2300 Australians.

J I Westbrook1, N J Talley.   

Abstract

BACKGROUND: : There is limited knowledge of the diagnostic investigation rates and use of prescription and non-prescription drugs amongst dyspeptics. AIM: : To assess the investigation rates and use of prescription and non-prescription anti-ulcer medications amongst dyspeptics in the population.
METHODS: : A cross-sectional survey was performed of 2300 Australians.
RESULTS: : Of 748 dyspeptics, 422 (56%) had consulted a doctor regarding dyspepsia at some time in their life. Of the consulters, 64% had undergone investigations at some time: 37% an endoscopy, 54% a barium meal and 27% both. A diagnosis of peptic ulcer was reported by 31% of those investigated. The symptom profile of gastroscopy patients differed significantly from that of uninvestigated dyspeptics. Of the consulters, 36% had taken anti-ulcer prescription drugs in the last 3 months: Histamine-2 receptor antagonists (73% of prescriptions), proton pump inhibitors (17%), cytoprotectants (5%) and prokinetic drugs (5%). Antacids were taken by 30% of non-consulting dyspeptics, 44% of consulters not on prescription drugs and 58% of dyspeptics taking prescription drugs. Advancing age, but not gender, was associated with diagnostic investigation and prescription and non-prescription drug usage.
CONCLUSIONS: : There are high rates of diagnostic investigation amongst dyspeptics who consult doctors. Many individuals with dyspepsia decide to self-medicate with antacids regardless of consulting or prescriptions, suggesting that current management is suboptimal.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12752354     DOI: 10.1046/j.1365-2036.2003.01555.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  4 in total

1.  Managing dyspepsia in a primary care setting.

Authors:  A Kenneth Musana; Steven H Yale; Kevin A Lang
Journal:  Clin Med Res       Date:  2006-12

2.  Prevalence of symptoms and use of medication for gastroesophageal reflux in an Australian community.

Authors:  David I Watson; Carolyn J Lally
Journal:  World J Surg       Date:  2009-01       Impact factor: 3.352

3.  Upper gastrointestinal endoscopy for dyspepsia: exploratory study of factors influencing patient compliance in Greece.

Authors:  Eirini Oikonomidou; Foteini Anastasiou; Ioannis Pilpilidis; Elias Kouroumalis; Christos Lionis
Journal:  BMC Gastroenterol       Date:  2011-02-14       Impact factor: 3.067

4.  Systematic Review With Meta-analysis: Prompt Endoscopy As the Initial Management Strategy for Uninvestigated Dyspepsia in Asi (Aliment Pharmacol Ther 2015;41:239-252).

Authors:  Hye-Kyung Jung
Journal:  J Neurogastroenterol Motil       Date:  2015-07-30       Impact factor: 4.924

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.